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Abstract
A novel glutamate-binding protein was identified in Schistosoma mansoni. The protein (SmGBP) is related to metabotropic
glutamate receptors from other species and has a predicted glutamate binding site located within a Venus Flytrap module
but it lacks the heptahelical transmembrane segment that normally characterizes these receptors. The SmGBP cDNA was
cloned, verified by 59 and 39 Rapid Amplification of cDNA Ends (RACE) and shown to be polyadenylated at the 39end,
suggesting the transcript is full-length. The cloned cDNA was subsequently expressed in bacteria and shown to encode a
functional glutamate-binding protein. Other studies, using a specific peptide antibody, determined that SmGBP exists in
two forms, a monomer of the expected size and a stable but non-covalent dimer. The monomer and dimer are both present
in the membrane fraction of S. mansoni and are resistant to extraction with high-salt, alkaline pH and urea, suggesting
SmGBP is either an integral membrane protein or a peripheral protein that is tightly associated with the membrane. Surface
biotinylation experiments combined with western blot analyses and confocal immunolocalization revealed that SmGBP
localized to the surface membranes of adult male schistosomes, especially the dorsal tubercles. In contrast, we detected
little or no expression of SmGBP either in the females or larval stages. A comparative quantitative PCR analysis confirmed
that the level of SmGBP expression is several-fold higher in male worms than cercariae, and it is barely detectable in adult
females. Together, the results identify SmGBP as a new type of schistosome glutamate receptor that is both gender- and
stage-specific. The high-level expression of this protein in the male tubercles suggests a possible role in host-parasite
interaction.
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Introduction
The parasitic flatworm, Schistosoma mansoni is the major cause of
human schistosomiasis, a disease that afflicts nearly 200 million
people worldwide [1]. S. mansoni has a complex life cycle that
requires two hosts, a freshwater snail of the genus Biomphalaria and
the definitive mammalian (human) host. Humans become infected
when free-living freshwater larva of S. mansoni (cercariae) penetrate
the skin and are quickly transformed into a parasitic larval stage
(schistosomula). The newly transformed larvae then enter the
circulation and undergo a complex migration through the lungs
and heart towards the hepatoportal system, where they continue to
develop to adult male and female worms and egg production
begins. The pathology associated with schistosomiasis is due
mainly to granulomatous inflammatory responses induced by large
numbers of eggs that become lodged in host tissues. The arsenal of
drugs available for treatment of schistosomiasis is very limited.
Praziquantel is the only drug available in most parts of the world
and there are growing concerns about the prospect of drug
resistance. There is an urgent need to learn more about the basic
biology of this organism and to identify new molecular targets for
drug development.
The nervous system of schistosomes is an attractive target for
chemotherapeutic intervention. S. mansoni has a well developed
central nervous system (CNS) and an extensive peripheral system
of minor nerve fibers and plexuses that coordinate all major
activities of the parasite [2]. Of particular interest as potential
drug targets are components of the nervous system that control
neuromuscular signaling related to movement, host attachment
and migration, as well as sensory neurons located at the surface
that may be involved in host-parasite interactions. A number of
neurotransmitter systems and receptors have been identified in S.
mansoni [2–4]. Here we focus our attention on L-glutamate, an
important neurotransmitter of many vertebrate and invertebrate
phyla. Glutamate-containing neurons have been identified in a
variety of flatworm species [5–8], including S. mansoni [9], and
there is evidence implicating glutamate in the regulation of
neuromuscular activity in these worms. For example, glutamate
was shown to stimulate muscle contraction when applied onto
isolated muscle fibers of S. mansoni [10] and muscle strips of the
tapeworm, Hymenolepis diminuta [11]. Moreover, treatment of
cultured schistosomes with glutamate agonists produced strong
body wall contractions and hyperkinesis [12], suggesting a
probable role in the coordination of the somatic muscles and
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largely unknown. There are several predicted glutamate receptors
encoded in the genomes of S. mansoni [13] and the related
schistosome species, S. japonicum [14] but most of these receptors
have yet to be characterized at the molecular level.
In other organisms, glutamate exerts its effects by interacting
with multiple types of cell-surface receptors, both ionotropic gated
channels and metabotropic glutamate receptors (mGluRs) [15].
The mGluRs belong to the superfamily of G protein-coupled
receptors (GPCR) and share a common heptahelical transmem-
brane (7-TM) topology. Vertebrates have eight mGluRs, which
are classified according to three major groups based on sequence
homology and mechanisms of signal transduction. Group I
receptors (mGluR1 and mGluR5) are coupled to Gq/11 proteins
and signal through changes in intracellular calcium and the
inositol phospholipid pathway. In contrast, Group II (mGluR2
and mGluR3) and Group III receptors (mGluR4, mGluR6,
mGluR7 and mGluR8) bind to Gi/o proteins and signal primarily
through inhibition of adenylate cyclase and a decrease in cellular
cAMP [15]. Besides vertebrates, mGluRs have also been identified
in several invertebrate species, particularly insects and nematodes.
Group I, II and III mGluR homologues have been described in
Drosophila and Caenorhabditis elegans [16,17] suggesting these major
groups of receptors diverged early in evolution. In addition, insects
have a type of mGluR (named mGluR X) that is distantly related
to Groups II/III receptors and may be unique to invertebrates
[18].
All vertebrate and invertebrate mGluRs cloned to date belong
to a subset of GPCRs (Family C) that also includes metabotropic
c-aminobutyric acid (GABA) receptors, calcium-sensing, taste and
pheromone receptors, among others. Family C GPCRs have a
distinctive modular structure, consisting of a large N-terminal
extracellular domain (ECD), followed by the signature 7-TM
segment and an intracellular C-terminal region of variable length.
The ECD of mGluRs contains the glutamate binding site located
within a Venus Flytrap module and is connected to the 7-TM
region by a short cysteine-rich linker [19]. The ECD is structurally
related to bacterial periplasmic binding proteins (PBP) and they
share a common mechanism of ligand binding [20]. It has been
suggested that the modular structure of mGluRs evolved from
fusion of two genes encoding a bacterial –like periplasmic binding
protein and an ancestral heptahelical (7-TM) membrane receptor
[21]. mGluRs may function as monomers, dimers and larger
oligomeric species. Dimerization, in particular, has been well
demonstrated among these receptors and plays an important role
in ligand binding and activation [22–24].
The S. mansoni genome encodes at least three sequences that
share homology with mGluRs from other species [13]. We have
previously reported that one of these sequences, named SmGluR,
encodes a functional glutamate receptor, which is expressed in part
in the worm’s central nervous system [25]. In this study we
describe the second and most unusual of these predicted receptors.
The S. mansoni glutamate-binding protein (SmGBP) reported here
resembles the ECD of a metabotropic glutamate receptor but lacks
the remaining domains, including the signature 7-TM region.
Genes encoding similarly truncated receptors were found in the S.
japonicum genome [14] and the partially annotated genome of the
planarian, Schmidtea mediterranea [26] but are not known to occur in
other metazoans. We conclude that SmGBP represents a new type
of glutamate receptor, one that may be unique to flatworms. Here
we provide a first investigation of this novel schistosome receptor
through biochemical analyses, functional expression studies and
confocal immunolocalization.
Materials and Methods
Parasites
A Puerto Rican strain of S. mansoni was used in all the
experiments. Biomphalaria glabrata snails infected with S. mansoni
were obtained from Dr. F. Lewis, Biomedical Research Institute
(Bethesda, MD). Snails were induced to shed after light exposure
and cercariae were mechanically transformed into schistosomula,
as described [27,28]. Adult worms were obtained 6–8 weeks post-
infection of 28 day-old CD1 female mice by portal perfusion [27].
When required, males and females were separated by incubating
freshly recovered worms in Dulbecco’s Modified Eagle Medium
(DMEM) (Invitrogen) for 4 h at room temperature. All animal
procedures were approved by a McGill University Facility Animal
Care Committee (FACC) and were performed in accordance to
FACC animal protocol # 3346.
Cloning of SmGBP
An expressed sequence tag (EST) was first identified in the S.
mansoni EST database as a partial mGluR (Sm10811) [29]. The
missing 59 and 39ends were obtained by RACE (Rapid
Amplification of cDNA Ends) procedures, using commercial kits
(Invitrogen). For the 39RACE, total RNA was extracted from adult
S. mansoni with TRIzolH reagent (Invitrogen) and reverse-
transcribed using the oligo-dT anchor primer supplied by the
kit. The resulting cDNA was used in a PCR with a sense gene-
specific primer (59-TGGGTGGGGTAGAGAAAATG-39) and
the kit antisense primer targeting the anchored sequence. Nested
PCR was done using an internal gene-specific primer (59-
CATCATTACCTTCATCGTGC-39) and the same reverse
anchor primer. For 59RACE, total RNA from adult S. mansoni
was reverse-transcribed using a gene-specific primer (59-GTAG-
TACCCAAAGTTAAACCTG-39) and an anchor sequence was
added to the 59end, according to the kit protocol (59RACE,
Invitrogen). The resulting cDNA was used as a template for PCR,
using a forward primer targeting the 59 end anchored sequence
(supplied by the kit) and a gene-specific reverse primer (59-
CCAAGCATTATATCACCTG-39). A second round of PCR was
done using a gene-specific internal primer (59-TATAATAG-
TAACCAAATGAAAC-39) as antisense and the same anchor
primer as sense. The 39 and 59 RACE products were cloned into
pGEMH-T Easy Vector (Promega) and confirmed by DNA
sequencing of multiple clones. For expression of recombinant
SmGBP, the predicted coding sequence was amplified directly
from oligo-dT reverse-transcribed total RNA extracted from adult
S. mansoni. The open reading frame of SmGBP has two potential
start codons that are 15 bp apart (positions 184 and 199 of full
length cDNA). To clone the coding sequence, we amplified a
1452bp cDNA from oligo-dT reverse-transcribed adult S. mansoni
RNA, using primers that targeted the second start codon at
position 199 (forward primer: 59-ATGTTGATTACTTTAAT-
GATTATATTATGG-39) and the predicted stop codon at
position 1650 (reverse primer: 59-CTAACGTATAAACTCAC-
CAGTAAATG-39). Efforts to amplify a product from the first
predicted start codon were unsuccessful, despite repeated attempts.
The final product was cloned into pJET1.2/blunt vector
(Fermentas) and confirmed by sequencing of two separate clones.
Antibody production
A polyclonal anti-SmGBP antibody was purchased from
Antagene, Inc. (Sunnyvale, CA, USA). The antibody was pro-
duced in rabbits against two synthetic peptides corresponding to
positions 53-67 (GVTTCESINPERGIQ) and positions 461-475
(CLEKMLSYPGTAFYQ) of SmGBP. Each of the peptides was
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Peptide sequences were examined by BLAST analysis against the
Schistosome Genome Database as well as the general protein
database at The National Center for Biotechnology Information
(NCBI) (http://www.ncbi.nlm.nih.gov/) to insure specificity.
Antisera were tested first against the two peptides by an ELISA
test and shown to be of high titer. The antiserum was subsequently
preadsorbed to KLH (Sigma) and then affinity-purified using the
MicroLink
TM Peptide Coupling kit (Pierce), as described previ-
ously [30].
Western blotting and immunoprecipitation of native
SmGBP
A membrane protein fraction was prepared from adult S.
mansoni, using the ProteoExtractHNative Membrane Protein
Extraction Kit (Calbiochem) as described in the kit protocol. For
western blotting, equal amounts of membrane proteins and the
remainder, predominantly soluble proteins (< 10 mg) were
resolved on a precast 4-12% gradient Tris-Glycine SDS-PAGE
gel (Invitrogen), transferred onto PVDF filters and incubated
overnight with peptide-purified anti-SmGBP antibody (dilution
1:2000). The blots were washed and incubated with Horseradish
Peroxidase (HRP)-conjugated goat anti-rabbit antibody (Calbio-
chem) (dilution 1:20,000) and western positive bands were
detected using standard procedures. Immunoprecipitation (IP)
was performed using the SeizeHPrimary Immunoprecipitation kit
(Pierce). Briefly, IP affinity columns were prepared by coupling
200 mg of anti-SmGBP antibody to AminolinkH Plus gel overnight
at 4uC and then washed extensively. Solubilized S. mansoni
membrane proteins were prepared with the Protein Extraction
Kit described above and aliquots containing 50 mg of protein were
loaded onto the IP column for 4 hours at room temperature. The
column was washed extensively and the bound protein was eluted
under acidic (pH 2.8) conditions, as described in the kit protocol.
The eluted protein was immediately neutralized to pH 7.4 by
addition of 50 mM Tris-HCl, pH 9.5. The acidic and neutralized
samples were both tested by western blot analysis with affinity-
purified anti-SmGBP antibody, as described above. In some
experiments, the neutralized protein samples were incubated with
0.1 M dithiotheritol (DTT), 1% triton X-100 or 6 M urea at 37uC
for 30 min prior to western blot analysis.
Sequential extraction of S. mansoni proteins
To test whether SmGBP is a soluble or membrane protein, we
performed sequential extractions with high salt, alkaline pH and
finally urea [31]. Adult S. mansoni (about 60 mg wet weight) were
homogenized in buffer containing 2 M NaCl, 10 mM HEPES-
NaOH, pH 7.4, 1 mM EDTA (ethylene diaminetetraacetic acid)
and then centrifuged at 125,000g for 15 min at 4uC. The resulting
pellet was resuspended in 0.1 M Na2CO3, 1 mM EDTA, pH 11.3,
incubated on ice for 30 min and the insoluble material was
collected by centrifugation as before. The pellet was resuspended
in 10 mM HEPES-NaOH pH 7.4, containing 4 M urea, 100 mM
NaCl and 1 mM EDTA. The final pellet containing membranes
was obtained by centrifugation for 20 min, 4uC at 125,000g. A
protease inhibitor cocktail (Sigma Protease Inhibitor Cocktail) was
used throughout the entire experiment (added at 1:100 final
concentration). Aliquots of all supernatant fractions and the final
resuspended pellet were subjected to SDS-PAGE on a 4-12% Tris-
Glycine gel (Invitrogen) and blotted onto a PVDF membrane.
Western blot was done using affinity-purified anti-SmGBP
antibody (dilution 1:2000) and anti-rabbit Horseradish Peroxi-
dase-conjugated secondary antibody (1:20,000 dilution).
Expression of SmGBP in mammalian cells
The 1452bp coding sequence of SmGBP was ligated between
the SalI and NotI restriction sites of mammalian expression vector,
pCI-neo, and the resulting The pCIneo-SmGBP plasmid was used
for transient transfection of HEK-293 cells, using Fugene6
(Roche), according to the manufacturer’s recommendations.
Protein expression in the transfected cells was monitored by in situ
immunofluorescence, as described previously [32], using affinity-
purified anti-SmGBP antibody. The soluble and membrane
fractions of transfected HEK-293 cells or mock transfected controls
were extracted using the ProteoExtractHNative Membrane Protein
Extraction Kit (Calbiochem), as above, and were tested for the
presence of SmGBP by western blot analysis, using the same
antibody. IP studies of transfected HEK-293 cells were performed
exactly as described for the native protein, except that the
recombinant SmGBP was found to be soluble in the mammalian
cell environment and therefore was isolated from the cytosolic
(rather than membrane) protein fraction. Aliquots of soluble
proteins from SmGBP-expressing HEK-293 cells or mock-trans-
fectedcontrols were loadedontoan anti-SmGBPIPcolumnandthe
protein was eluted, neutralized and probed with affinity-purified
anti-SmGBP antibody, as described above.
Immunolocalization of SmGBP in S. mansoni
For immunofluorescence confocal microscopy experiments,
adult S. mansoni and larvae were prepared as previously described
[25,30]. Animals were incubated with peptide-purified anti-
SmGPB antibody (dilution 1:150) for 3-4 days at 4 uC with gentle
agitation. Animals were washed overnight and then treated with
Fluorescein Isocyanate (FITC)-conjugated goat anti-rabbit IgG
antibody (Chemicon) (dilution 1: 1000) for 4 days at 4 uC. As
a counterstain, we added 200 mg/ml of phalloidin-tetramethyl
rhodamine isothiocyanate (TRITC) for the last three days of
incubation with the secondary antibody. The samples were
examined using a BIO-RAD RADIANCE 2100 confocal laser
scanning microscope equipped with a Nikon E800 fluorescence
microscope for confocal image acquisition and the LASER-
SHARP 2000 analyzing software package. Controls used in these
studies include (1) replacement of the primary antibody with pre-
immune serum (2) omission of the primary antibody (3) pre-
adsorption with an excess of the combined SmGBP peptide
antigens (0.25 mg/ml of each peptide).
Surface biotinylation of live S. mansoni
S. mansoni surface labeling was done according to the method of
Braschi and Wilson [33]. Freshly recovered adult worms were
washed with Hanks’ balanced salt solution (HBSS) (Invitrogen)
and examined first under the microscope. Damaged worms were
removed and were not used in the experiment. The worms were
incubated with EZ-LinkH sulfo-NHS-LC-Biotin (Pierce) (1.5 mg/
ml prepared in HBSS) with gentle agitation at 4uC for 30 min.
The reaction was terminated by washing the worms in RPMI
1640 (Invitrogen). To verify the labeling and integrity of the
schistosome surface membrane, freshly labeled worms were
incubated with PierceH Streptavidin Fluorescein conjugated
(1:100 dilution) for 30 min at room temperature with end-over-
end rotation. The worms were washed with RPMI 1640 and
examined by confocal microscopy as above. For further analysis, we
prepared a solubilized membrane fraction from biotin-labeled
worms, using the same ProteoExtractHNative Membrane Protein
Extraction Kit described earlier (Calbiochem). Biotinylated mem-
brane proteins were subsequently purified with PierceH Streptavidin
Agarose Resin, according to the manufacturer’s recommendations.
Briefly, aliquots of membrane proteins (40 mg) were incubated with
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centrifugation at 500g for 1 min at 4uC to remove unbound
proteins. The resin was then washed five times with PBS
(phosphate-buffered saline) and the bound biotinylated proteins
were recovered by heating the sample in 1x SDS-PAGE sample
buffer for 5 min at 90uC. Aliquots of total biotin-labeled membrane
proteins, unbound proteins and streptavidin-purified (recovered)
proteins were resolved by SDS-PAGE, blotted onto a PVDF
membrane and probed both with streptavidin-horseradish perox-
idase conjugate (Amersham) and anti-SmGBP antibody.
Real-time quantitative PCR (qPCR) analyses
Total RNA was extracted from S. mansoni cercariae, adult males
and females, using the RNeasy kit (Qiagen). The RNA was
quantified with a Nanodrop ND1000 spectrophotometer (Wil-
mington, USA) and equal amounts of RNA from each stage
(approximately 100 ng) were used for oligo-dT reverse-transcrip-
tion, using M-MLV reverse transcriptase (Invitrogen), according to
standard protocols. The real-time qPCR reaction was done with
the Platinum SYBR Green qPCR SuperMix-UDG kit (Invitro-
gen), according to the kit protocol in a Rotor-Gene RG3000
(Corbett Research) real-time PCR cycler. The primers for qPCR
were designed so as to amplify a SmGBP product of 127 bp
(forward: 59- TAACTGGACTTATGTTTCC-39 and reverse: 59-
ATTTCCTCTAATCACTTCTC-39) or a 206 bp fragment of S.
mansoni glyceraldehyde-3-phosphate dehydrogenase (GAPDH;
Accession# M92359; forward: 59-GTTGATCTGACATGTA-
GGTTAG-39; reverse: 59-ACTAATTTCACGAAGTTGTTG-39).
GAPDH was used as a housekeeping gene for data normalization.
The PCR cycling conditions were as follows: 50 uC/2 min, 95 uC/
2 min followed by 50 cycles of 94 uC/15 s, 50 uC/30 s and 72 uC/
30 s. Non-template and minus reverse-transcriptase controls were
included in every experiment and the specificity of the PCR
products was tested by melting curve analysis. Quantification of
relative differences in expression was done by using the comparative
DDCt method [34].
Bacterial expression and purification of SmGBP
For functional studies in E. coli, the 1452bp coding sequence of
SmGBP was amplified by PCR using primers designed to add
BamHI and XhoI restriction sites at the 59- and 39-ends,
respectively. The terminal stop codon was removed to add a six
histidine tag at the C-terminal end of the expressed protein. The
amplified sequence was then subcloned between the BamHI and
XhoI sites of the pET prokaryotic expression vector, pET22b
(Novagen). Thisvector carries a pelB signal sequence for periplasmic
expression of cloned proteins. The resulting pET22b-SmGBP
construct was confirmed by sequencing and then used to transform
Escherichia coli host strain BL21 (DE3)pLysS (Novagen). The
transformed E. coli cells were grown in LB (Luria-Bertani) liquid
media supplemented with ampicillin and chloramphenicol at 37uC
until the OD600 value reached 0.6-1 and the culture was then
induced with 1 mM IPTG (Isopropyl b-D-thiogalactopyranoside)
for 3 hours at 30uC. The periplasmic protein fraction containing
recombinant SmGBP was isolated by osmotic shock, as described
previously [35]. The cells were washed once with cold PBS then
subjected to osmotic shock by incubation in 5 mM Tris–HCl, 20%
sucrose, pH 8 for 10 min at room temperature with occasional
vortexing and finally pelleted at 4uC. The cell pellet was
resuspended in 10 ml ice-cold 5 mM MgSO4 containing a cocktail
ofproteaseinhibitors(SigmaProtease InhibitorCocktail,1:100 final
concentration) and the cell suspension was mixed gently for 10 min
on ice to release the periplasmic proteins. The remaining cell
material was removed by centrifugation (10,000g for 10 min at 4uC)
and aliquots of the supernatant containing recombinant oligohis-
tidine-tagged SmGBP (SmGBP-His) were used directly for protein
purification.The protein was purifiedby immobilized-nickel affinity
chromatography, using HisNBind Resin and Buffer Kit from
Novagen (EMD Biosciences, US), according to the kit protocol.
The purified protein was immediately concentrated by ultrafiltra-
tion with a Centricon-10 microconcentrator (Amicon) and washed
twice with storage buffer (0.2 M NaCl, 50 mM Tris-HCl and 10%
glycerol, pH 7.2). The purification was verified by SDS-PAGE on a
4-12% Tris-Glycine gradient gel (Invitrogen) and western blotting
with affinity - purified anti-SmGBP antibody. Aliquots of the
purified SmGBP-His protein (final concentration 1 mg/ml) were
frozen at -80uC in the same storage buffer until use.
Ligand-binding assays
[
3H]glutamate binding assays were performed as described
previously [36]. Briefly, 5 ml( 5mg) of purified SmGBP-His were
incubated with 1 mlo f[
3H]glutamate (specific activity 49.6 Ci/
mmol; 1 mCi/ml) (Perkin Elmer-Canada) in 150 ml of binding
buffer (40 mM HEPES, pH 7.5 and 2.5 mM CaCl2) in the
absence or presence of different concentrations (0.1 nM to
100 mM) of unlabelled glutamate for 1 h at 4uC. The bound
ligand was recovered by the polyethylene glycol (PEG) precipita-
tion method [36]. 6 kDa PEG (Sigma) and c-globulin (Sigma)
were added to final concentrations of 15% and 3 mg/ml,
respectively, and the samples were centrifuged for 15 min at
4uC. The precipitated material was washed twice, each for 10 min
with binding buffer containing 8% 6 kDa PEG. The pellet was
resuspended in 1ml of water and added to 5 ml of scintillation fluid
(Universol
TM, ICNBiomedicals, CA). Radioactivity was measured
using a 1414 WinSpectral
TM, Wallac scintillation counter. The
same protocol was repeated in competition studies with glutamine,
aspartate (Sigma) and various mGluR agonists and antagonists,
including ((S)-3,5-DHPG, (S)-3,5-Dihydroxyphenylglycine; DCG
IV, (2S,29R,39R)-2-(29,39-Dicarboxycyclopropyl)glycine); L-AP4,
L-(+)-2-Amino-4-phosphonobutyric acid; (S)-MCPG, (S)-a-Meth-
yl-4-carboxyphenylglycine; LY 341495, (2S)-2-Amino-2-[(1S,2S)-
2-carboxycycloprop-1-yl]-3-(xan th-9-yl) propanoic acid), each at a
final concentration of 10 mM. Neurochemicals were purchased
from Tocris Bioscience, USA.
Other methods
To test the specificity of the anti-SmGBP antibody, indirect
ELISA was performed in 96-well plates coated with SmGBP
peptides (1 mg/well) and a serial dilution (1: 250,000-1:50) of
rabbit anti-SmGBP antiserum or pre-immune serum, followed by
incubation with a HRP-labeled goat anti-rabbit IgG (dilution
1:1000) antibody, according to the standard protocols. Protein
concentration was determined by the Lowry method, using a
commercial kit from BioRad Canada. Data analysis was done with
the Prism software package for the Macintosh version 3.0a
(Graphpad Software, San Diego, CA, USA). ClustalW protein
sequence alignments and the construction of phylogenetic trees
were performed with MacVector 7.1.1 (Accelrys, Inc.). Trees were
built according to the Neighbour-Joining method using the Best
Tree mode available in MacVector and were verified by bootstrap
analysis with 1000 iterations. The homology model of SmGBP was
generated from a structural alignment with the crystal structure of
rat mGluR 3 (Protein Data Bank (PDB) accession # 2e4u), using
the modeling tools available at MODBASE [37] and was
visualized with FirstGlance in Jmol version 1.45. Statistical
comparisons were done with Student t-tests or a one-way analysis
of variance (ANOVA) followed by a Tukey’s pairwise analysis, as
required. A P ,0.05 was considered statistically significant.
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Cloning of SmGBP
A search of the S. mansoni EST database (http://bioinfo.iq.usp.
br/schisto/) [29] identified a sequence (886bp) that resembled
mGluRs from other species. This sequence was first amplified
from oligo-dT reverse-transcribed adult S. mansoni cDNA. The
missing 59 and 39 ends were subsequently obtained by RACE and
verified by DNA sequencing of multiple clones. The complete
cDNA has (1863 bp), including a stretch of 59untranslated
sequence (183 bp) followed by a large continuous open reading
frame (ORF) of 1467 bp and a segment of 39untranslated region
(213 bp), which contains a polyA
+ tail (Accession # HM483390).
Following completion of the S. mansoni genome sequencing project,
the predicted genomic sequence for SmGBP was annotated and
designated Smp_052660 (CAZ32804.1) [13]. The genomic
sequence is identical to that of the cloned cDNA, except for five
nucleotide substitutions that result in amino acid changes at
positions 21, 52, 84, 403 and 477 of the SmGBP protein sequence.
Sequence analysis
The SmGBP cDNA has two potential start codons that are 15
bp apart (positions 184 and 199 of full length cDNA). The longest
open reading frame (1467 bp) encodes a protein of 488 amino acid
residues and a predicted molecular weight of 55 kDa. Blastp
homology searches combined with multisequence alignments
determined that SmGBP is closely related to the extracellular
ligand binding region of metabotropic glutamate receptors but,
surprisingly, lacks the remaining domains that normally charac-
terize these receptors. The cysteine-rich linker (CRD), the 7-TM
transmembrane segment and the C-terminal intracellular domain
are all missing in the schistosome protein (Fig. 1A). These regions
are also absent in the current annotation of the SmGBP genomic
sequence available at NCBI (Smp_052660). As noted above, the
cDNA was thoroughly verified by RACE analysis and sequencing
of multiple clones, with particular emphasis on the 39 end. We
found no other forms of SmGBP that contained the missing
sequence. Moreover, SmGBP was found to be polyadenylated at
the 39 end as would be expected of a mature, properly processed
transcript. Thus we conclude that SmGBP encodes a C-terminally
truncated mGluR. Further analysis of the primary protein
sequence identified a hydrophobic peptide at the N-terminus that
could be a signal peptide or possibly a single transmembrane
domain (position 10-27).
A hypothetical homology model of SmGBP was subsequently
generated by using the rat mGluR3 extracellular domain as a
Figure 1. SmGBP is a C-terminally truncated metabotropic glutamate receptor. (A) Predicted structure of Schistosoma mansoni SmGBP
(Accession # HM483390) and a closely related Schistosoma japonicum homologue SjGBP (Sjp 0088520.1) compared to the crystal structure of rat
mGluR3 (group II subtype 3) receptor (2e4u). The cartoon illustrates the expected domain architecture of metabotropic glutamate receptors (mGluR).
The extracellular binding domain (ECD) includes a conserved Venus Flytrap module, which contains the glutamate binding region and is linked to the
heptahelical membrane-anchoring segment (7-TM) by a cysteine-rich domain (CRD). The 7-TM segment is followed by an intracellular C-terminal
domain (IC) of variable length. The amino acid positions of the various domains in mGluR3 are marked. Compared to the rat receptor, the
schistosome SmGBP and SjGBP sequences contain the ligand binding region but lack the remaining cysteine-rich, membrane spanning and
intracellular domains. (B) Hypothetical homology model of SmGBP showing the characteristic bilobed Venus Flytrap architecture of the mGluR ligand
binding domain. The model was generated from an alignment with the crystal structure of rat mGluR3 (2e4u) using the modeling tools available at
MODBASE [37]. (C) Predicted ligand binding residues of SmGBP were identified by comparison with known glutamate binding sites of mGluR3 [38].
Binding sites that are conserved in SmGBP include (corresponding mGluR3 position): Arg68 (Arg68), Ser144 (Ser151), Thr167 (Thr174), Tyr215 (Tyr222) and
Asp297 (Asp301).
doi:10.1371/journal.pone.0027119.g001
Glutamate Receptors in Schistosoma mansoni
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27119structural template. The model suggests that SmGBP has the
characteristic bilobed Venus Flytrap structure of the mGluR
ligand binding region and shows many conserved glutamate
binding residues, suggesting this is a functional binding protein
(Fig. 1B). Residues that have been directly implicated in glutamate
binding in the rat mGluR3 receptor [38] and are conserved in
SmGBP include Arg68, Ser144, Thr167, Tyr215 and Asp297. (Fig. 1C).
When compared to the general database at NCBI, SmGBP was
found to be most closely related to insect, nematode and vertebrate
mGluRs (Blastp E values ,2 84). In addition, SmGBP shares
sequence homology with other glutamate receptors of S. mansoni,
including the previously described SmGluR [25], as well as
predicted mGluRs of flatworm species for which genome
sequences are available, notably Schistosoma japonicum and the
planarian Schmidtea mediterranea. A search of the S. japonicum
database available at GeneDB (http://www.genedb.org/) found
a protein sequence (Sjp 0088520) of 485 amino acid residues that
is almost identical to SmGBP (92% homology) and another highly
homologous 486 amino acid sequence was detected in the S.
mediterranea genome database (v31.015264) (http://smedgd.neuro.
utah.edu) [26]. Interestingly, these two flatworm proteins are also
C-terminally truncated and lack the same domains (cysteine-rich
linker, the heptahelical transmembrane segment and the carboxy
intracellular domains) as SmGBP.
Phylogenetic trees were constructed from a ClustalW multi-
sequence alignment of mGluRs from various vertebrate and
invertebrate (insect, nematode, flatworm) species, along with other
related Family C GPCRs (GABA, calcium-sensing and taste
receptors) and bacterial periplasmic binding proteins (PBP) as the
outgroup (Fig. 2). The analysis shows the different GPCRs clearly
separated on the tree. The major groups of mGluRs (Groups I, II,
III) [15] and the insect-specific mGluRX receptors [18] are also
shown. Compared to these sequences, the flatworm receptors
represent the earliest divergence from the mGluR ancestor. The
S. mansoni SmGluR receptor [25] and a related S. japonicum
homologue (Sj mGluR7) diverged first and constitute a separate
branch in the mGluR tree. SmGluR is only distantly related to
vertebrate mGluRs but it was shown to be selectively activated by
glutamate in vitro [25] and therefore it is considered to be a
functional receptor. The remaining flatworm sequences in this
alignment are the truncated receptors, SmGBP, S. japonicum SjGBP
and the planarian homologue (Fig. 2, boxed sequences), which also
constitute a separate branch in the tree. These sequences diverged
after SmGluR but before the separation of the major groups of
glutamate receptors. Thus we conclude that schistosomes have at
least two different and novel types of mGluR-like proteins
represented by SmGluR, SmGBP and their S. japonicum homo-
logues. In addition, there is one more predicted mGluR in S.
mansoni (Smp_153370) [13] and a related partially annotated S.
japonicum sequence (Sjp_0094830) [14], which could constitute a
third type of receptor (not shown).
Immunoprecipitation experiments
To investigate SmGBP at the protein level, we obtained a
specific polyclonal antibody targeting two unique SmGBP
peptides. The antibody was affinity-purified and tested first against
recombinant SmGBP expressed in HEK-293 cells. In situ
immunofluorescence assays showed that the antibody recognized
cells transfected with SmGBP expression plasmid (pCIneo-
SmGBP) but not the control cells transfected with empty plasmid
(Fig. S1). SmGBP was subsequently immunoprecipitated from
transfected HEK-293 cell lysates, using anti-SmGBP antibody that
was covalently linked to agarose beads. Proteins were eluted from
the antibody-coupled beads under acidic conditions (pH 2.8),
neutralized (pH 7.4) and then immunoblotted with affinity-purified
anti-SmGBP (Fig. 3A). The results showed two species of SmGBP,
one corresponding roughly to the size of the monomer (<60 kDa)
and a larger species of about twice the size at <115 kDa. Neither of
these bands could be seen in the mock-transfected control and
therefore they were considered to be specific. The 60 kDa band was
predominant in the initial acidic eluate. However, upon neutrali-
zation we saw an increase in the proportion of the 115 kDa species
and a corresponding decrease in the intensity of the 60 kDa band
(Fig. 3A), suggesting the two species are interconvertible. mGluRs
are known to form stable dimers that resist denaturation on SDS-
PAGE and can be either covalent or non-covalent in nature [22-
24,39,40].Ourresultssuggestthatthe 115 kDaspeciesisprobablya
non-covalent, pH-sensitive SmGBP dimer that becomes dissociated
at acidic pH. To test whether these forms of SmGBP also exist in S.
mansoni, we performed IP experimentson adult S. mansoniextracts. A
preliminary western blot analysis determined that SmGBP was
enriched in the membrane fraction of S. mansoni and therefore we
immunoprecipitated SmGBP from purified S. mansoni membrane
proteins, using the same anti-SmGBP antibody-coupled beads. The
IP results are virtually identical to those obtained with the
recombinant protein. In both cases, the anti-SmGBP antibody
detected a predominant < 115 kDa species at neutral pH and a
band of about half the size (< 60 kDa) when the sample was
acidified (Fig. 3B). Further analysis revealed that the 115 kDa
species was resistant to treatment with a reducing agent (0.1M
DTT) and detergent (1% triton-x100) but it could be made to
dissociate partially upon treatment with 6 M urea and it was
completely dissociated at acidic pH, such that only the monomer (<
60 kDa) was visible at pH < 3 (Fig. 3C). This supports the notion
that the larger SmGBP species is a stable but non-covalent, pH-
sensitive dimer. No bands were detected in IP eluates probed either
with preimmune serum or a peptide-preadsorbed antibody control
(Fig. 3B).
SmGBP is a membrane-associated protein in S. mansoni
Since SmGBP lacks its 7-TM membrane-anchoring segment,
we questioned whether this protein was associated with the
membrane, as expected of a cell surface receptor, or whether it
was expressed as a soluble protein. In preliminary experiments, we
isolated membrane proteins from adult S. mansoni, using a
commercial kit, and then immunoblotted both the membrane
fraction and the remaining (predominantly soluble) fraction with
the specific anti-SmGBP peptide antibody. The results of this
preliminary analysis revealed that the native SmGBP was enriched
in the membrane fraction and was associated with the same two
major western positive bands (< 60 and 115 kDa) described
above. To verify these results, we performed sequential extractions
of S. mansoni proteins and examined each step by western blot
analysis (Fig. 4). First, we homogenized adult worms in high-salt
solution (2 M NaCl) to release both cytosolic (soluble) and loosely
associated peripheral membrane proteins (S1). This was followed
by treatment with high pH carbonate buffer, which breaks
membrane-bound vesicles and releases their protein content into
the supernatant, and where proteins associated peripherally with
the membrane can also be found (S2). In the last step, 4 M urea
was used to remove tightly associated peripheral proteins from the
membrane (S3) and the remaining pellet (P4) was expected to
contain predominantly integral membrane proteins [31]. Western
blotting with affinity-purified anti-SmGBP antibody revealed that
SmGBP was extracted after treatment with urea (S3) but a
significant amount was retained in the final pellet, mostly as the
larger MW (< 115 kDa) species (Fig. 4). Thus we conclude that
the native SmGBP is either an integral membrane protein, or a
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membrane.
Expression of SmGBP in adult male S. mansoni
The tissue localization of SmGBP in adult and larval stages was
subsequently examined by confocal immunofluorescence, using
affinity-purified anti-SmGBP antibody followed by an FITC-
labeled secondary antibody. Analysis of cercariae and schistosom-
ula stages found no detectable SmGBP expression. Likewise, we
did not see any immunoreactivity in female worms, apart from
inconsistent fluorescence in the vitellaria and intestinal caeca,
which could also be detected in some of the controls and was
Figure 2. Dendogram analysis showing the relationship of SmGBP with structurally related receptors from S. mansoni and other
species. The amino acid sequences were aligned using the ClustalW method and a Neighbor-Joining Best Tree was constructed from the multiple
sequence alignment. Included in the alignment are representative examples of all major groups of metabotropic glutamate receptors (mGluR Groups
I, II, III), an insect-specific group of mGluRs (Group X) and several flatworm mGluR-like sequences. For comparison, we also included other types of
metabotropic (Family C) G protein-coupled receptors (calcium-sensing, taste and c-aminobutyric acid (GABA) receptors) along with bacterial
periplasmic binding proteins (PBP) as the outgroup. Five bacterial PBP sequences were included in the alignment (Accession # AAC13287,
AAM84023; BAB40635; ZP_03825963; YP_011745770) but they were omitted from the tree for simplicity. The tree was rooted to one of the bacterial
PBPs (Accession # YP_011745770) and was tested by bootstrap analysis with 1000 iterations. The length of the branches is proportional to the
genetic distance between sequences and bootstrap values (normalized to 100) are provided for selected key branches. Sjp_0022600 (SjmGluR7) and
Sjp_0088520 (SjGBP) are predicted protein sequences obtained from the S. japonicum genome database [14] available at GeneDB (http://www.
genedb.org/); V31.015264 is a prediction from the Schmidtea mediterranea genome database (http://smedgd.neuro.utah.edu) [26]. The remaining
protein sequences were obtained from the general database available at the National Center for Biotechnology Information (NCBI) and are identified
by their corresponding accession numbers. Species abbreviations are as follows: Aa, Aedes aegypti; Ag, Anopheles gambiae; Am, Apis mellifera; As,
Ascaris suum; CEL, Caenorhabditis elegans; Dd, Dictyostelium discoideum; Dm, Drosophila melanogaster; Dr, Danio rerio; Dv, Drosophila virilis; Pp, Pongo
pygmaeus; Sk, Saccoglossus kowalevskii; Sm, Schistosoma mansoni; Sj, Schistosoma japonicum. The truncated flatworm receptors are boxed and the S.
mansoni sequences are identified by arrowheads. mGluR, metabotropic glutamate receptor; GBP, glutamate binding protein (truncated mGluR).
doi:10.1371/journal.pone.0027119.g002
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expressed in adult male worms. Expression in the males was
confined to the surface layer, especially the dorsal tubercles, and
was seen along the length of the body (Fig. 5A). Counterstaining
with TRITC-conjugated phalloidin revealed the somatic muscles
located beneath the tegument but no co-localization of SmGBP
(green) with cytoskeletal elements or muscle (red) could be seen. In
the tubercles, the green SmGBP fluorescence is surrounded by red
actin-rich spines, again with no detectable co-localization (Fig. 5B).
No comparable green fluorescence could be seen in any of the
controls done, including peptide antigen preadsorbed antibody
control (Fig. 5C), omission of primary antibody or pre-immune
serum.
Biotinylation of S. mansoni surface proteins
Biotinylation experiments were done to verify the surface
localization of SmGBP. We used a hydrophilic biotinylated
reagent (EZ-LinkH sulfo-NHS-LC-Biotin) that is excluded by the
schistosome membranes and will bind proteins near the surface of
an intact worm [33]. The labeled proteins were then recovered by
affinity-coupling to streptavidin. Before labeling, the worms were
examined carefully under the microscope to check the integrity of
the surface membrane and the biotinylation was monitored with
streptavidin-FITC conjugate. FITC fluorescence was consistently
observed on the surface of the worm, as expected (Fig. 6A, B) but
not inside the animal (Fig. 6C). Aliquots of total biotin-labeled
membrane protein, unbound and streptavidin-purified proteins
were tested in western blotting using streptavidin-horseradish
peroxidase (HRP) conjugate to verify biotin labeling. Streptavidin
binding was detected in the total biotin-labeled membrane and the
recovered fraction, while very little, if any, was seen in the
unbound fraction, as expected (Fig. 6D). Streptavidin-recovered
protein was subsequently probed with anti-SmGBP antibody to
test if the receptor was present in this protein fraction. The
antibody recognized the same two bands of the expected size,
<60 kDa and 115 kDa, of which the largest species is the most
abundant.
Quantitative analysis of SmGBP mRNA expression
The confocal immunolocalization experiments suggest that
SmGBP is enriched in males and may be absent in females and
larval stages. Subsequent western blot analyses of membrane
protein extracts from cercariae and 5-day old schistosomula also
failed to detect SmGBP (data not shown). To verify these results,
we measured expression of SmGBP at the mRNA level by real-
time qPCR. Equal amounts of male, female and cercaria RNA
were used in a reverse-transcription qPCR experiment, which also
included a minus reverse-transcriptase control to detect genomic
contamination and a non-template control. Data were normalized
relative to a housekeeping gene (GAPDH) and changes in
expression level were calculated by the DDCT method [34], using
cercariae as our stage of reference. The results confirmed our
earlier observations from the protein studies. The level of SmGBP
expression in adult males is < 12 fold higher than that in cercariae
(Student’s t- test: P value = 0.02). Females have barely detectable
expression levels, representing approximately 1/3 of the cercarial
level (0.338, Student’s t- test: P value = 0.000135) and nearly 40
times less than the males (Fig. 7).
Bacterial expression of SmGBP
The 1452bp coding sequence of SmGBP was amplified by
PCR, cloned into the prokaryotic vector pET22b and expressed in
E. coli BL21(DE3)pLysS as a C-terminal oligo-histidine fusion
protein. The pET22b vector is designed to direct the expressed
protein to the periplasmic space. Periplasmic expression was
selected for this study because SmGBP was found to be toxic to
the bacterium when overexpressed in the cytoplasm. The histidine-
tagged SmGBP was purified by nickel affinity chromatography and
tested first by western blot analysis with anti-SmGBP antibody. The
results identified the same two western-positive bands at < 60 kDa
and115 kDa(Fig.8A).Thepurifiedproteinwassubsequentlytested
for glutamate binding activity. Aliquots of recombinant His-tagged
SmGBP were incubated with a constant amount of [
3H]glutamate
in the presence of increasing concentrations of unlabelled glutamate
Figure 3. Immunoprecipitation (IP) of recombinant and native SmGBP. Recombinant SmGBP was immunoprecipitated from transfected
HEK-293 cell lysates (A) and native SmGBP was immunoprecipitated from a preparation of solubilized S. mansoni membrane proteins (B, C), as
described in the text. In both cases, the IP was performed with anti-SmGBP antibody that was covalently linked to agarose beads. The protein was
eluted from the beads at pH 2.8 (acidic) and the eluate was subsequently neutralized to pH 7.4 (neutral pH). Aliquots of the acidic and neutralized IP
eluate were immunoblotted with peptide purified anti-SmGBP antibody. Under acidic conditions the antibody identified one major band at <
60 kDa, whereas upon neutralization the antibody recognized a second band at < 115 kDa both in transfected HEK-293 cells and S. mansoni.N o
bands were seen in the negative controls, either HEK-293 cells transfected with empty plasmid (mock) or blots probed with preimmune serum
(control). (C) Native SmGBP was immunoprecipitated as above and treated with 0.1 M DTT, 1% triton X-100, 6 M urea or acid conditions (pH 2.8) prior
to western blotting with anti-SmGBP antibody. The positions of relevant molecular weight markers are shown.
doi:10.1371/journal.pone.0027119.g003
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24 M) and the binding affinity was calculated by non-
linear curve fitting of the resulting competition curve (IC50 0.3 6
0.05 mM) (Fig. 8B). To test whether SmGBP recognizes classical
(mammalian) mGluR ligands, we repeated the [
3H]glutamate
competition assays with different glutamatergic agonists and
antagonists in addition to glutamine, aspartate and glutamate itself
(Fig. 8C). Several of the test drugs were able to compete with
[
3H]glutamate, AP4 (mGluR III agonist) and S)-MCPG (mGluRs
I/II antagonist) being the strongest, followed by (S)-3,5-DHPG
(mGluRI agonist), whereas DCG IV (mGluR II agonist) and
Ly341495 (mGluR II antagonist) were poor competitors (<50%
inhibition). Among the amino acids, glutamate was the strongest
competitor, as expected, but we also observed competition by
glutamine and aspartate (77% and 84% inhibition of [
3H]
glutamate binding, respectively), suggesting that SmGBP can also
recognize these amino acids.
Discussion
L-Glutamate is a major excitatory neurotransmitter in the CNS
of vertebrates and many invertebrate phyla but its role in
schistosomes is poorly understood. Here we describe one of at
least three mGluR-like sequences encoded in the S. mansoni
genome [13]. SmGBP is an unusual receptor; it is a C-terminally
truncated mGluR that has a conserved glutamate binding site but
lacks the heptahelical and intracellular domains. The predicted
protein sequence was deduced from the genomic DNA sequence,
which is similarly truncated, and was verified experimentally by
RACE and cloning of the cDNA. Shorter variants of mGluRs
have been described in mammalian species but these are produced
from alternative splicing of longer transcripts and usually retain
the 7-TM membrane anchoring region. The majority of mGluR
splicing events that have been reported to date occur within the
intracellular C-terminal tail and do not involve the transmem-
brane domains [41]. In a few instances, however, researchers have
reported unusually short splice variants that lack the entire 7-TM
region and are similar in length to SmGBP. The best example is
the human mGluR3 receptor, which exists both as a full-length
GPCR and a C-terminally truncated variant of unknown function
that carries only the ECD [42]. We considered the possibility that
SmGBP might also be encoded by a longer gene sequence that has
yet to be annotated. However, we could not identify any splice
variants of SmGBP using RACE techniques. More than ten 39
RACE clones were examined and all were found to be similarly
truncated. In addition, the SmGBP cDNA was found to be
polyadenylated, suggesting that the transcript is mature and
properly processed in the worm. Thus we conclude that SmGBP is
expressed, at least in part, as a short receptor. We cannot,
however, rule out the possibility of a longer variant of this protein
that could not be detected in this study.
The ECD of eukaryotic mGluRs is distantly related to
periplasmic amino acid binding proteins (PBPs) normally seen in
bacteria. Bacterial PBPs constitute a large family of proteins that
mediate transmembrane transport of a variety of nutrients,
including amino acids, and they also play an important role in
signaling, for example in chemotaxis [43]. They lack transmem-
brane domains and are expressed either as soluble proteins in the
periplasmic space of gram-negative bacteria, or are attached to the
cytoplasmic membrane via a lipid anchor in gram-positive bacteria
[44]. Amino acid- binding PBPs share significant structural
homology with the Venus Flytrap module of mGluRs and are
believed to have a common origin. It has been suggested that
glutamate receptors have evolved from the fusion of a bacterial
PBP gene with a gene encoding the membrane anchoring region,
either a channel in the case of ionotropic receptors, or a
heptahelical 7-TM receptor in the case of mGluRs [21,45]. This
raises interesting questions about the evolution of the truncated
schistosome receptor. One possibility is that SmGBP might be
related to an ancestor of mGluRs that existed before the gene
fusion event but the phylogeny makes this seem unlikely. Our
sequence analyses show that SmGBP is more closely related to
mGluRs than to bacterial PBPs. Moreover the other schistosome
glutamate receptor (SmGluR) is a full-length protein that
comprises both the ligand binding domain and the 7-TM region
[25], indicating that modular mGluRs already existed in the
ancestor of flatworms. An alternative, more plausible explanation
is that SmGBP evolved from a full-length eukaryotic receptor but
subsequently lost its C-terminal half, perhaps by introduction of
splicing signals that over time resulted in the loss of 39 end exons.
We have found truncated sequences similar to SmGBP in S.
japonicum and the planarian, S. mediterranea, but not in vertebrates or
other invertebrates. Thus SmGBP is conserved within the phylum
and could be a flatworm-specific adaptation.
To further characterize this protein, we obtained a polyclonal
antibody against two SmGBP-specific peptides. Western blot
analyses of proteins from S. mansoni and HEK-293 cells expressing
SmGBP detected a band at <60 kDa and a second band of about
115 kDa in both systems. These bands were not present in the
mock-transfected cells or any of the antibody controls, which
Figure 4. Native SmGBP is a membrane –associated protein.
S. mansoni peripheral and integral membrane proteins were fraction-
ated by sequential extraction in high salt, alkaline pH and urea, as
described in the text. Aliquots of the supernatants after extraction in
2 M NaCl (S1), bicarbonate buffer, pH 11.3 (S2), 4 M urea (S3) and the
final pellet (P4) were immunoblotted with peptide-purified anti-SmGBP
antibody. The antibody recognized two major bands corresponding to
the monomer and predicted dimer in the S3 supernatant after 4 M urea
extraction as well as in the final pellet.
doi:10.1371/journal.pone.0027119.g004
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results we immunoprecipitated SmGBP from both S. mansoni and
transfected HEK-293 cells, using the same antibody, and then the
purified proteins were tested by western blotting. Once again, two
major SmGPR species of about 60 kDa and 115 kDa were
consistently observed. The 60 kDa corresponds roughly to the
expected size of the SmGBP monomer (55 kDa). The small
difference could be due to glycosylation at any one of 4 possible N-
glycosylation sites (positions 81, 202, 308 and 479) and also the
high pI of the protein (pI = 9.0), which is known to cause aberrant
migration on SDS-PAGE. The second, larger immunoreactive
band of 115 kDa is likely a SmGBP dimer that resists denaturation
on SDS-PAGE gels. SDS-resistant dimers are common for G
protein-coupled receptors and recent work has shown that most
family C GPCRs, including mGluRs are obligate dimers [22,
39,40]. Dimerization is necessary for receptor activation; gluta-
mate binding to one ECD causes only partial activation, and
binding to both domains is required for full activation [23,24].
Several structural mechanisms are involved in mGluR dimeriza-
tion. Early studies identified covalent interactions due to disulfide
bonds located within the N-terminus [39]. However non-covalent
interactions involving the extracellular region have also been
proposed [46]. The dimer of SmGBP is most probably formed by
non-covalent interactions since it was found to be resistant to a
reducing agent (DTT) but it could be made to dissociate when
treated with agents that disrupt non-covalent bonds, such as urea
and low pH.
To test for binding activity, SmGPB was expressed in E. coli as
an oligohistidine-tagged protein and purified by metal-chelation
chromatography. The purified SmGBP was shown to bind
glutamate specifically and in a dose-dependent manner, and also
recognized some glutamatergic agents, for example, agonists
DHPG and AP4 and the antagonist, MCPG. Glutamine and
aspartate were both competitors of [
3H] glutamate but not as
potent as unlabelled glutamate itself. The results show that
SmGBP is a functional glutamate-binding protein. This is
consistent with earlier studies of truncated forms of recombinant
mGluRs. The ECDs of mGluR1, mGluR4 and mGluR8 were all
expressed heterologously as soluble proteins and were shown to
retain their ligand binding activity [47,48].
SmGBP lacks the heptahelical membrane domain and therefore
it was expected to be a soluble protein. Surprisingly, however, we
found the native protein to be enriched in the membrane fraction
of S. mansoni. Moreover, our biochemical analysis suggests that the
association with the membrane is strong, consistent with that of a
tightly-bound peripheral or integral membrane protein. These
results are similar to a recent investigation of the truncated splice
variant of the mammalian mGluR3 receptor, which also lacks its
7-TM segment and yet was found to be associated with the plasma
membrane [42]. In this case, the authors identified a short
hydrophobic segment located at the C-terminal end that was
predicted to serve as a single transmembrane domain [42]. The
sequence analysis of SmGBP detected a putative TM domain at
the N-terminal end. It is possible that SmGBP is inserted into the
membrane via this N-terminal TM region. Alternatively, SmGBP
may attach to the membrane by non-covalent interactions with a
membrane component, for example another protein, or it may be
covalently linked to a membrane lipid, similar to the PBP-like
proteins of gram-positive bacteria [44]. The sequence analysis of
SmGBP did not show high probability of covalently bound lipid
anchors (palmitoylation, myristoylation or glycosylphosphatidyli-
nositol (GPI)) but this possibility cannot be ruled out.
To elucidate the function of SmGBP in S. mansoni, we examined
the tissue localization using a specific antibody. Previously,
glutamate was detected in the nervous system of S. mansoni [9]
and glutamate agonists were reported to have an effect on motor
Figure 5. Tissue localization of SmGBP. S. mansoni were probed with affinity-purified anti-SmGBP antibody followed by a FITC-labeled
secondary antibody. (A) Strong immunoreactivity (green) was detected on the surface layer of adult male worms (open arrows). Actin-rich muscles
were stained with TRITC-labeled phalloidin (red) and can be seen beneath the tegument (solid arrow heads). At higher magnification, the SmGBP
signal was found to be enriched in the tubercles (arrows) of the male, where numerous actin-rich phalloidin-labeled spines (red) can also be seen (B).
No significant SmGBP immunofluorescence was detected in male worms probed with peptide-preadsorbed antibody (C). Besides males, we did not
observe specific SmGBP immunoreactivity in any of the other stages tested, including cercariae (D) schistosomula and female worms (not shown).
doi:10.1371/journal.pone.0027119.g005
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the peripheral innervation of the musculature but, surprisingly, no
expression was detected in these sites. Instead, SmGBP localized to
the surface layer of male worms, especially the tubercles, and there
was no visible association with the subtegumental muscles in
phalloidin-labeled animals. Subsequent biotinylation experiments
detected significant SmGBP immunoreactivity in the steptavidin-
purified biotinylated fraction, again suggesting that the protein is
located at or near the parasite surface. Interestingly, we could not
detect SmGBP protein either in female worms or larval stages,
including the free-living larvae (cercariae) or schistosomula. This
selective expression in males was also observed at the RNA level.
The qPCR experiments showed that SmGBP was upregulated
several-fold in adult males compared to cercariae and it was barely
detectable in female worms. A previous microarray transcriptome
analysis of S. mansoni identified SmGBP (Smp_052660) as one of
the genes showing differential expression between male and female
worms [49]. Our results support this earlier analysis.
The tissue localization of SmGBP offers possible clues about
its function in schistosomes. The absence of the protein in
neuromuscular structures suggests this is probably not the receptor
responsible for the previously described motor effects of glutamate;
rather the data suggest that SmGBP is involved in some other form
of glutamate signaling that occurs at the parasite surface. The
tubercles, where SmGBP is enriched, are protuberances of the
male dorsal surface. Several neurotransmitters and neuronal
proteins have been identified in the tubercles of schistosomes,
Figure 6. Surface biotinylation of adult S. mansoni. Adult male worms were incubated with EZLink
TM sulfo-NHS-LC-biotin followed by
streptavidin- FITC conjugate. Examination of biotinylated animals by confocal microscopy showed that the labeling was confined to the surface (A, B).
No significant penetration of streptavidin-FITC could be seen in the internal tissues or gut (C). Western blot analyses (D) were performed on aliquots
of total biotinylated proteins (total), streptavidin-purified proteins (recovered) and the flow-through (unbound). Blots were probed first with
streptavidin-conjugated to HRP to verify biotin labeling and recovery of biotinylated proteins. The streptavidin-purified fraction (recovered) was
subsequently probed with anti-SmGBP antibody. The relevant molecular weights are indicated.
doi:10.1371/journal.pone.0027119.g006
Figure 7. Developmental and gender-specific expression of
SmGBP. Quantitative PCR was performed on reverse-transcribed cDNA
from S. mansoni adult males, females and cercariae. The data were
normalized to S. mansoni GAPDH, which was used as an internal
housekeeping gene. Differences in expression were calculated accord-
ing to the comparative DDCT method [34]. The results are shown as
fold-change in S. mansoni SmGBP expression relative to cercariae. Data
are the means and SEM of seven independent experiments, each in
duplicate.
doi:10.1371/journal.pone.0027119.g007
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endings [28,50–53]. The pattern of SmGBP immunoreactivity
resembles that of other neuronal proteins in these regions,
suggesting the receptor could be expressed in nerve endings along
the surface of male worms and could play an important role in
chemosensory signaling, either as part of an endogenous pathway
or in response to exogenous (host-derived) glutamate.
Although SmGBP can bind glutamate, it lacks the mid- and C-
terminal regions required for signaling and therefore it is unlikely
to have activity on its own. Its effects are probably mediated by
interactions with other proteins that are present in the tubercles.
Efforts to identify SmGBP-interacting partners using co-immuno-
precipitation and proteomics methods have not been successful
thus far (data not shown) and therefore the identity of these
proteins remains unclear. One possibility is that SmGBP binds to
another glutamate receptor to modulate signaling activity. In
mammals there is evidence that a truncated mGluR mutant can
dimerize with the full-length receptor and the interaction is
dominant negative, resulting in decreased signaling. This effect is
believed to represent an important mechanism of mGluR
regulation in mammalian cells [54] and it is possible that SmGBP
functions in a similar manner in S. mansoni. SmGBP is unlikely to
interact with the previously described SmGluR schistosome
receptor because their tissue distributions are quite different [25]
but there is at least one more predicted mGluR in the genome
whose distribution is unknown [13] and there could be other
potential partners that have yet to be identified.
SmGBP may have functions that are unrelated to neuronal
signaling. The location of the protein so close to the surface raises
the possibility that some of the receptor is associated with the male
tegument. The tegument is a specialized syncytial epithelium that
covers the entire length of the worm, including the tubercles, and
plays a variety of key roles, notably in nutrient transport, immune
evasion and interactions with the host [55]. A tegumental
glutamate receptor could be used to mediate host-parasite
communication, as suggested for a number of other receptors
that have been localized to the schistosome tegument [28,53,56].
In addition, given the prevalence of SmGBP in males, we note that
many of the genes that are upregulated in male schistosomes are
involved in macromolecule transport and overall energy produc-
tion [57]. SmGBP could interact with a tegumental transporter to
mediate glutamate intake from the host, a function similar to that
of PBPs in bacteria, or it could bind to a metabolic tegumental
enzyme that requires glutamate for activity.
In summary, we have identified a novel glutamate receptor that
diverged early in evolution and lacks several of the conserved
domains normally seen in eukaryotic mGluRs. The unusual
structure of this protein, combined with its surface location make
Figure 8. [
3H] Glutamate binding assay. (A) SmGBP was expressed in E.coli (BL21) as a C-terminal oligohistidine fusion protein, purified by affinity
chromatography and tested by western blotting with anti-SmGBP antibody. The antibody identified two immunoreactive protein species
corresponding to the SmGBP monomer and dimer (B) Purified His-SmGBP was incubated with [
3H] glutamate and increasing concentrations (10
210 to
10
24) of unlabelled glutamate for 1 h at 4uC and the bound ligand was recovered by polyethylene glycol (PEG) precipitation. The data were
normalized relative to the maximum level of [
3H] glutamate binding measured in the absence of cold ligand and each point is the mean and SEM of
four experiments done in duplicates. (C) Purified His-SmGBP was incubated with a constant amount of [
3H] Glutamate and an excess of test
substance, each added at 10 mM. Experiments were performed using glutamate, glutamine, aspartate and the following glutamatergic ligands: (S)-
3,5-DHPG ((S)-3,5-Dihydroxyphenylglycine), DCG IV (2S,29R,39R)-2-(29,39-Dicarboxycyclopropyl)glycine), L-AP4 (L-(+)-2-Amino-4-phosphonobutyric
acid), (S)-MCPG ((S)-a-Methyl-4-carboxyphenylglycine), LY 341495 ((2S)-2-Amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xan th-9-yl) propanoic acid).
Data were normalized relative to the control sample that contained [
3H] glutamate without competitor. The results are the means and SEM of four
separate experiments, each in duplicate. For aspartate and glutamine, the data are derived from two experiments, each in triplicate. All drugs tested
were significantly different from the no drug control at P ,0.05.
doi:10.1371/journal.pone.0027119.g008
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More research is needed to elucidate the functional role of this
receptor in the parasite.
Supporting Information
Figure S1 Heterologous expression of S. mansoni SmGBP in
cultured mammalian cells. HEK293 cells were transiently
transfected with expression plasmid pCIneo-SmGBP (panels B,
C) or empty plasmid as a control (panel A). Cells were fixed and
permeabilized with ice-cold methanol, as described [28,32] and
were subsequently incubated with affinity-purified anti-SmGBP
antibody, followed by a secondary Fluorescein Isocyanate (FITC)-
conjugated antibody. Cells were counterstained with 49,6-diami-
dino-2-phenylindole (DAPI) and examined by confocal microsco-
py. FITC fluorescence (green), DAPI fluorescence (blue) and the
overlay of the two signals are shown for each of the three panels.
The results show strong FITC immunoreactivity in cells expressing
SmGBP but not the mock transfected control.
(TIF)
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